Skip to content

096760.KS

JW Holdings Corporation

KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR

KRW 4,180.00
+0.00%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue1010.8B969.0B887.7B928.1B864.5B
Cost of Revenue507.4B496.6B452.5B481.9B464.6B
Gross Profit503.9B472.9B435.2B446.2B400.0B
Operating Expenses
R&D Expense47.7B48.9B39.1B33.7B33.1B
SG&A Expense181.5B149.8B146.1B150.6B240.6B
General & Admin Expense96.5B95.7B90.8B91.8B81.3B
Selling & Marketing Expense55.4B54.1B55.3B58.9B64.7B
Other Expenses110.5B110.6B103.5B116.9B116.4B
Total Operating Expenses322.9B309.3B288.7B301.3B273.8B
Cost and Expenses820.0B805.9B741.2B784.4B738.3B
Operating Income (EBIT)190.4B163.7B146.5B143.7B110.7B
Non-Operating
Interest Income8.1B3.2B7.1B6.7B445.9M
Interest Expense19.4B19.9B32.2B32.5B25.3B
Net Interest Income(11.2B)(16.6B)(25.0B)(25.8B)(24.8B)
Other Non-Op Income/Expense(12.6B)(19.4B)11.6B(90.3B)(39.7B)
Non-Operating Income (excl Interest)3.8B(43.8B)59.4B8.0B
EBT (Pre-Tax Income)177.8B144.3B158.1B53.4B71.0B
Income Tax Expense21.1B28.8B35.4B22.4B24.5B
Bottom Line
Net Income84.5B58.5B62.6B19.0B22.2B
Earnings from Cont. Ops156.7B115.5B122.8B31.0B46.5B
Earnings from Discont. Ops
Bottom Line Net Income84.5B58.5B62.6B19.0B22.2B
Per Share
Basic EPS₩1,219₩841₩874₩265₩306
Diluted EPS₩1,219₩841₩874₩265₩306
Revenue Per Share₩14,609₩13,904₩12,394₩13,219₩11,964
Shares
Basic Shares Outstanding69.2M69.7M71.6M70.2M72.3M
Diluted Shares Outstanding69.2M69.7M71.6M70.3M72.3M
Profitability Metrics
EBITDA149.6B207.3B231.4B128.5B142.8B
D&A44.8B43.6B41.1B44.2B40.1B
EBIT104.8B163.7B190.3B84.3B102.7B

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026